Teresita Mazzei
Florence, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Breakthrough Cancer Pain Clinical Features and Differential Opioids Response: A Machine Learning Approach in Patients With Cancer From the IOPS-MS Study.
Journal: JCO precision oncology
Published: October 02, 2020
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy.
Journal: International journal of cancer
Published: November 08, 2018
Trabectedin in combination with pegylated liposomal doxorubicin in patients with ovarian tumors.
Journal: Molecular and clinical oncology
Published: January 31, 2018
The most appropriate therapeutic strategy for acute lower respiratory tract infections: a Delphi-based approach.
Journal: Journal of chemotherapy (Florence, Italy)
Published: March 17, 2017
Future trends in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection: An in-depth review of newer antibiotics active against an enduring pathogen.
Journal: Journal of global antimicrobial resistance
Published: March 08, 2017
Stable disease in a patient with metastatic leiomyosarcoma treated with trabectedin.
Journal: Anti-cancer drugs
Published: February 10, 2017
Methicillin-resistant Staphylococcus aureus infections: A review of the currently available treatment options.
Journal: Journal of global antimicrobial resistance
Published: January 11, 2016
Urological infections due to multidrug-resistant bacteria: what we need to know?
Journal: Urologia
Published: April 07, 2015
Pharmacological aspects of the antibiotics used for urological diagnostic procedures.
Journal: Journal of chemotherapy (Florence, Italy)
Published: September 24, 2014
Therapeutic recommendations of the multidisciplinary group.
Journal: Journal of chemotherapy (Florence, Italy)
Published: September 24, 2014
MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin.
Journal: The pharmacogenomics journal
Published: May 02, 2014
Last Updated: 09/26/2026